open access

Vol 5, No 1 (2004): Practical Diabetology
Original articles (submitted)
Published online: 2004-02-02
Get Citation

Occurrence of diabetic maculopathy according to diabetes control and hypertension prevalence

Marta Misiuk-Hojło, Maria Magnowska-Woźniak, Piotr Marszalik
Diabetologia Praktyczna 2004;5(1):15-22.

open access

Vol 5, No 1 (2004): Practical Diabetology
Original articles (submitted)
Published online: 2004-02-02

Abstract

INTRODUCTION. Diabetic retinopathy is nowadays most common microvascular complication in diabetic patients. Macular damage is inseparable feature of retinopathy and it is the main reason of visual acuity reduction. Hyperglycaemia is dominant pathogenic factor in angiopathy, however in some cases the systemic factors, especially hypertension, can have a harmful effect.
MATERIAL AND METHODS. 101 diabetic patients were observed. Diabetic maculopathy was diagnosed in 168 eyes. Diabetes control level and results of treatment were estimated by means of fructosamine level. From all patients we obtained visual acuity, ophthalmoscopy and fluorescein angiography. Function of central retina was evaluated by means of visual acuity. Retina was investigated in direct ophthalmoscopy. Angiography was also used in macula assessment.
RESULTS. Maculopathy was observed more often in hypertensive patients: 63,6% had focal, 30,3% had diffuse and 6,1% had ischaemic maculopathy. Pharmacological normalization of hypertension had a positive effect on the type of macular damage and had a correlation with milder types of maculopathy. In sufficient and insufficient diabetes control level more often diffuse (68,5%) and ischaemic (66,6%) maculopathy were found. In perfect and good diabetes control level more often types were: focus (60%) and diffuse (31,8%) maculopathy.
CONCLUSIONS. Diabetic maculopathy occurred more often in hypertensive patients and had milder course in patients with normalized hypertension. We also proved a beneficial effect of diabetes control on types of maculopathy.

Abstract

INTRODUCTION. Diabetic retinopathy is nowadays most common microvascular complication in diabetic patients. Macular damage is inseparable feature of retinopathy and it is the main reason of visual acuity reduction. Hyperglycaemia is dominant pathogenic factor in angiopathy, however in some cases the systemic factors, especially hypertension, can have a harmful effect.
MATERIAL AND METHODS. 101 diabetic patients were observed. Diabetic maculopathy was diagnosed in 168 eyes. Diabetes control level and results of treatment were estimated by means of fructosamine level. From all patients we obtained visual acuity, ophthalmoscopy and fluorescein angiography. Function of central retina was evaluated by means of visual acuity. Retina was investigated in direct ophthalmoscopy. Angiography was also used in macula assessment.
RESULTS. Maculopathy was observed more often in hypertensive patients: 63,6% had focal, 30,3% had diffuse and 6,1% had ischaemic maculopathy. Pharmacological normalization of hypertension had a positive effect on the type of macular damage and had a correlation with milder types of maculopathy. In sufficient and insufficient diabetes control level more often diffuse (68,5%) and ischaemic (66,6%) maculopathy were found. In perfect and good diabetes control level more often types were: focus (60%) and diffuse (31,8%) maculopathy.
CONCLUSIONS. Diabetic maculopathy occurred more often in hypertensive patients and had milder course in patients with normalized hypertension. We also proved a beneficial effect of diabetes control on types of maculopathy.
Get Citation

Keywords

diabetes mellitus; diabetic maculopathy; hypertension

About this article
Title

Occurrence of diabetic maculopathy according to diabetes control and hypertension prevalence

Journal

Clinical Diabetology

Issue

Vol 5, No 1 (2004): Practical Diabetology

Pages

15-22

Published online

2004-02-02

Bibliographic record

Diabetologia Praktyczna 2004;5(1):15-22.

Keywords

diabetes mellitus
diabetic maculopathy
hypertension

Authors

Marta Misiuk-Hojło
Maria Magnowska-Woźniak
Piotr Marszalik

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl